The pathogenesis of androgenetic alopecia (AGA, male-pattern baldness) is driven by androgens, and genetic predisposition is the major prerequisite. Candidate gene and genome-wide association studies have reported that single-nucleotide polymorphisms (SNPs) at eight different genomic loci are associated with AGA development. However, a significant fraction of the overall heritable risk still awaits identification. Furthermore, the understanding of the pathophysiology of AGA is incomplete, and each newly associated locus may provide novel insights into contributing biological pathways. The aim of this study was to identify unknown AGA risk loci by replicating SNPs at the 12 genomic loci that showed suggestive association (5 Â 10
INTRODUCTION
Androgenetic alopecia (AGA, male-pattern baldness, Online Mendelian Inheritance in Man (OMIM 109200), OMIM 3010710, and OMIM 612421) is the most common form of hair loss in humans, and affects 80% of European men by the age of 80 years. AGA is characterized by a progressive loss of hair from the scalp (Hamilton, 1951; Norwood, 1975) , and changes in hair cycling are a key feature of its pathophysiology (Kaufman, 2002; Randall, 2007) . Research has established that the two major etiological factors for AGA are genetic predisposition and hormonal status (Hamilton, 1942 (Hamilton, , 1951 . The heritability of AGA is high, and has been estimated to be B80% in two independent twin studies (Nyholt et al., 2003; Rexbye et al., 2005) . Candidate gene and genome-wide association studies (GWASs), including a recent meta-analysis of seven GWASs, have identified strong associations between AGA and single-nucleotide polymorphisms (SNPs) at eight chromosomal loci (Ellis and Harrap, 2001; Hayes et al., 2005; Hillmer et al., 2005 Hillmer et al., , 2008a Levy-Nissenbaum et al., 2005; Prodi et al., 2008; Richards et al., 2008; Brockschmidt et al., 2010; Brockschmidt et al., 2011; Li et al., 2012) . Of these, the X-chromosomal androgen receptor/ectodysplasin A2 receptor locus (AR/ EDA2R) confers the strongest effect, and the androgen receptor is a highly plausible candidate gene at this locus.
However, no study has demonstrated an effect of genetic variation on the expression and function of the protein.
Similarly, for the seven autosomal loci, in some cases candidate genes have been suggested, such as histone deacetylase 9 on chromosome (chr) 7p21.1 (Brockschmidt et al., 2011; Li et al., 2012) and histone deacetylase 4 on chr2q37.3 (Li et al., 2012) , but no direct functional evidences have been obtained so far. Despite these recent breakthroughs in our understanding of the genetics of AGA, a significant fraction of the overall heritable risk still awaits identification. The identification of additional risk factors is highly desirable, as these may provide new insights into the pathophysiology of AGA and its underlying biological pathways. A promising strategy for the identification of additional genomic loci for AGA is to replicate SNPs at the genomic loci that showed suggestive association with AGA within the meta-analysis by Li et al. (2012) (Po10 À 5 ), but which fell above the threshold for genome-wide significance (P ¼ 5 Â 10
). This study involved two independent samples: first a German AGA case-control sample comprising 177 AGA cases and 272 supercontrols (460 years, no signs of AGA), and second a sample of European descent comprising 2,582 AGA cases and 2,389 controls.
RESULTS

Analysis of the data from the MAAN (Meta-Analysis for
Androgenetic Alopecia Novel Determinants) by Li et al. (2012) revealed a total of 12 genomic loci for which at least one SNP showed an association with AGA of Po1 Â 10 À 5 but fell short of genome-wide significance (P45 Â 10 À 8
; Table 1 ). For each of these 12 loci, the two SNPs with the best association P-values in the meta-analysis were genotyped in an independent German replication sample (''Replication I''). Of the 24 SNPs, 21 were genotyped successfully for 177 cases and 272 supercontrols. Of these, three SNPs at two distinct genomic loci showed nominally significant association with AGA (Po0.05; Table 1 ). However, only rs7349332 on chr2q35 showed a genome-wide significant association in a combined analysis of our data and the data of the previous meta-analysis (P ¼ 3.32 Â 10
; data not shown). We therefore attempted further replication using data from the scientific program of 23andMe (23andWe). All 24 SNPs were analyzed within the existing genome-wide data of 2,582 cases and 2,389 controls of European descent from 23andMe (''Replication II''). Of these, a total of 12 SNPs at 6 distinct genomic loci showed a nominally significant association with AGA (Table 1) . A combined analysis of the two replication studies and the published meta-analysis (Li et al., 2012) established genome-wide significant association with AGA for the regions on chr2q35, chr3q25.1, chr5q33.3, and chr12p12.1 (Table 1 , Figure 1 ). The strongest association was observed for rs7349332 on chr2q35 (P ¼ 3.55 Â 10
; odds ratio (OR) ¼ 1.34, 95% confidence interval (CI) ¼ 1.27-1.42), which is located intronically in WNT10A (wingless-type MMTV integration site family, member 10A) (Figure 1a ). This association finding on chr2q35 was further supported by rs10193725 (P ¼ 1.46 Â 10 À 10 ; OR ¼ 0.80, 95% CI ¼ 0.74-0.87), which is located B30 kb upstream of rs7349332 and intronically within WNT6, another member of the winglesstype MMTV integration site family. The AGA risk allele (T) for rs7349332 was associated with hair curl in two independent GWASs (Medland et al., 2009; Eriksson et al., 2010) . To investigate a potential etiological overlap between AGA and hair curl, we analyzed whether any other genome-wide significant loci for hair curl were associated with AGA, and whether any genome-wide significant loci for AGA were associated with hair curl. Aside from rs7349332 in WNT10A, there were no associations with Po0.05 after adjusting for multiple comparisons. The second best association was observed for a locus on chr5q33.3 comprising the two SNPs rs929626 (P ¼ 2.12 Â 10 ; OR¼ 1.17, 95% CI ¼ 1.12-1.22), both of which are located intronically within EBF1 (early B-cell factor 1) (Figure 1c ). On chr12p12.1, the best association signal was observed for rs9668810, with P ¼ 1.09 Â 10 À 10 (OR ¼ 1.21, 95% CI ¼ 1.15-1.27), followed by the 2.3-kb distal rs7975017 (P ¼ 4.03 Â 10 À 10 ; OR ¼ 1.21, 95% CI ¼ 1.15-1.28). Both SNPs on chr12p12.1 are located in the intergenic region between the two RefSeq genes SSPN (sarcospan) and ITPR2 (inositol 1,4,5-triphosphate receptor, type 2) (Figure 1d) . A similarly strong association signal was identified for a locus on chr3q25.1, with P-values of P ¼ 1.79 Â 10 À 10 (OR ¼ 1.19, 95% CI ¼ 1.13-1.24) and P ¼ 1.20 Â 10 À 9 (OR ¼ 1.18, 95% CI ¼ 1.12-1.23) for rs7648585 and rs4679955, respectively. Both SNPs are located in the intergenic region between the two RefSeq genes SUCNR1 (succinate receptor 1) and MBNL1 (muscleblind-like splicing regulator 1) (Figure 1b) . Although the direction of effects was consistent across all studies for the region on chr12q24.33 flanked by the two RefSeq genes TMEM132D (transmembrane protein 132D) and FZD10 (frizzled family receptor 10), this region failed to reach genome-wide significance in the combined analysis (P min ¼ 1.28 Â 10 À 6 ). In a second step, we investigated the expression of RefSeq genes located within a 200 kb window around the SNP with the lowest P-value at the respective AGA risk loci within human hair follicles (Table 2 ). On chr2q35, eight RefSeq genes were located within this 200 kb window. Of these, two genes showed expression in human hair follicle. The highest expression values were observed for CYP27A1 (cytochrome P450, family 27, subfamily A, polypeptide 1; average (AVG) signal ¼ 377.21), which is located 76.4 kb downstream of rs7349332. Hair follicle expression was also detected for WNT10A-which spans rs7349332-with an AVG signal of 86.36. On chr3q25.1 and chr5q33.3, no expression was detected for the investigated genes, i.e., SUCNR and EBF1, respectively. On chr12p12.1, both of the genes that flank the association finding showed expression in hair follicles. SSPN, which is located B38.7 kb downstream of rs9668810, showed an AVG signal of 70.55, and ITPR2, which is located B61.9 kb downstream of rs9668810, showed an AVG signal of 119.04.
We also tested for a genotypic effect on the expression of candidate genes showing expression in hair follicles. Interestingly, we observed a genotypic effect of rs7349332 on the expression of WNT10A, in which AGA risk allele carriers (1.14-2.10) Abbreviations: CI, confidence interval; EA, effect allele; I 2 , between-study variance; OA, other allele; OR, odds ratio; SNP, single-nucleotide polymorphism.
The replication I sample comprised 177 cases and 272 unaffected controls. The replication II sample comprised 2,582 cases and 2,389 controls. Regions that achieved genome-wide significant association with AGA in the combined analysis are printed in bold. All genomic positions are according to GRCh37/hg19.
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Androgenetic Alopecia and WNT Signaling (CT, TT; n ¼ 25) showed significantly reduced expression compared with nonrisk allele carriers (CC; n ¼ 71; P ¼ 0.03; Figure 2 ). We detected no genotypic effect of rs7349332 or rs9668810 on the expression of CYP27A1 or SSPN, respectively (data not shown). The observed tendency toward a lower expression of ITPR2 in homozygous AGA risk allele carriers (TT) for rs9668810 was not statistically significant (P ¼ 0.09; data not shown). To better understand the role Abbreviations: AGA, androgenetic alopecia; AVG, average; Chr, chromosome; OR, odds ratio; SNP, single-nucleotide polymorphism. Genes located closest to the best association finding at the respective locus are printed in bold. All genomic positions are according to GRCh37/hg19. of WNT10A and other WNT-related genes in the etiology of AGA, we also examined the interaction between the lead SNPs from loci in close proximity to genes related to WNT signaling (i.e., WNT6, WNT10A, WNT3, and FZD10). Moreover, we examined the interactions between the lead SNPs from the eight previously identified AGA risk loci (Li et al., 2012) , the four risk loci identified in this study, and the locus on chr12q24.33 (FZD10). We did not detect any interaction between rs7349332 (WNT10A) and any of the other loci; however, restricting the analysis to loci related to WNT signaling revealed a significant interaction between rs745077 (FZD10) and rs12373124 (WNT3) (P ¼ 0.02; data not shown).
DISCUSSION
This study identified four AGA risk loci with genome-wide significance on chromosomes 2q35, chr3q25, chr5q33.3, and chr12p12.1, and provides biological evidence that WNT10A is the gene responsible for the effect on chr2q35. WNT10A is a member of the family of WNT genes that encode small secreted signaling proteins. These proteins participate in diverse developmental processes during embryogenesis, as well as in adult tissue homeostasis (Logan and Nusse, 2004) . Numerous publications have indicated the importance of WNT signaling in hair development and hair cycling (Millar et al., 1999; Reddy et al., 2001; Andl et al., 2002; Fuchs, 2007) . In particular, some authors have suggested that WNT signaling constitutes an important regulatory signal for the transition from telogen to anagen in postnatal hair follicles (Reddy et al., 2001; Li et al., 2011) . Interestingly, WNT10A expression has been detected at anagen onset in mouse hair follicles (Reddy et al., 2001) , suggesting that WNT10A is implicated in anagen induction. A study by Shimizu and Morgan (2004) showed that WNT signaling is essential in the maintenance of anagen characteristics within dermal papilla cells. This finding is of particular interest, as changes in hair follicle dynamics are a key feature of AGA (Courtois et al., 1994) . During AGA development, the premature transition from anagen to telogen results in shorter hair growth phases and a reduction in the ratio of anagen to telogen follicles (Whiting, 1993; Courtois et al., 1994; Kaufman, 2002) . Moreover, the time interval between telogen and the initiation of a new hair cycle is prolonged, leading to a decrease in hair density (Ellis et al., 2002) . The regulation of hair cycle dynamics might be a plausible mechanism for how rs7349332 confers risk for AGA. The decrease in WNT10A expression observed in AGA risk allele carriers for rs7349332 might lead to a delay in telogen-anagen transition and a shortening of anagen duration, resulting in the changes in hair cycling described for AGA (Figure 3 ). The role of WNT signaling in AGA etiology is further supported by the fact that other genes related to WNT signaling are located in the vicinity of other AGA risk loci, e.g., WNT3 on the previously implicated chromosomal region chr17q21.31 and ITPR2 on chr12p12.1 implicated in our present study. Research suggests that the latter might act downstream of WNT signaling as a receptor for IP 3 (Wang and Malbon, 2004) . Interestingly, another member of the IP 3 receptor family has recently been proposed to actively regulate the process of hair shedding (Sato-Miyaoka et al., 2012) . Moreover, the locus on chr12q24.33 that shows evidence for association in our study-although not with genome-wide significance (P ¼ 1.28 Â 10 À 6 )-harbors FZD10, which encodes a known WNT receptor. Observations from clinical genetics also suggest that WNT10A may be implicated in hair growth. Homozygous mutations in WNT10A are a known cause of autosomal recessive odonto-onycho dysplasia (OMIM 257980 and OMIM 606268) , which may present with sparse scalp and body hair (Adaimy et al., 2007; Bohring et al., 2009) . Additional support for a role of WNT signaling in the etiology of AGA, although preliminary, was provided by our interaction analysis suggesting an interaction of FZD10 and WNT3. S Heilmann et al.
Androgenetic Alopecia and WNT Signaling
Although our data and evidence from the literature suggests that WNT10A is involved in the etiology of AGA, any such role needs to be substantiated by additional studies including detailed functional studies or, at the genetic level, by identifying independently associated WNT10A alleles through resequencing and high-resolution association studies.
The association finding on chr2q35 also suggests an unexpected link between AGA and hair structure. The AGA risk allele (T) of rs7349332 was associated with curly hair in two independent GWAS studies (Medland et al., 2009; Eriksson et al., 2010) . To our knowledge, no previous study has reported an association between AGA and curly hair at either a clinical or an epidemiological level. GWA studies enable investigation of whether this identified link is restricted to the WNT10A locus or whether it is more widespread, affecting additional genomic loci. As a preliminary step in this direction, we investigated whether the other genome-wide significant loci for AGA and curly hair were associated with the risk for the other trait. As this was not the case, the etiological overlap between the two traits may specifically involve the WNT signaling pathway. This hypothesis requires comprehensive investigation in large GWAS data sets.
In summary, this study provides genetic evidence for a contribution of WNT signaling to AGA etiology. We demonstrated that the AGA risk variant rs7349332 had a regulatory effect on WNT10A expression in the human hair follicle. This effect might be of functional relevance in the regulation of hair cycle dynamics. As WNT signaling has been implicated in a number of human disorders (Clevers and Nusse, 2012) , this pathway might account for some of the unexpected associations of AGA with common traits as described by Li et al. (2012) . The candidate genes for the genetic loci 3q25.1 and 5q33.3 remain unknown. Further studies using complementary strategies, such as re-sequencing and functional studies, are needed to identify these candidate genes and to further elucidate the actual functional causes that underlie these disease associations. As exemplified by the WNT10A finding, the identification of candidate genes on the basis of genetic association studies may provide new insights into AGA pathophysiology.
MATERIALS AND METHODS
Samples and DNA extraction
This replication study included two independent samples of European descent. For the ''Replication I'' sample, peripheral blood samples were collected from 177 unrelated AGA-affected males and 272 AGA-unaffected controls, all of German descent. The hair status of each participant was assessed by a dermatologist according to the Hamilton/Norwood (HN) classification. Affected men were aged o30 years with HN grades IV-VII, or o40 years with HN grades V-VII, and were thus representative of the most severely affected 10% of the distribution for the respective age classes (Hamilton, 1951; Norwood, 1975) . The controls were aged 460 years and showed no signs of AGA, and were thus representative of the 20% least affected individuals in the population. DNA from lymphocytes was isolated by salting out with saturated NaCl solution (Miller et al., 1988) , or using Chemagic Magnetic Separation Module I (Chemagen, Baesweiler, Germany) according to the manufacturer's instructions. The second sample (''Replication II'') comprised unrelated male individuals of European descent, selected from users of the 23andMe Personal Genome Service (Eriksson et al., 2010) . The affection status for AGA was measured by self-assessment through a web-based survey. Individuals with HN grade XIII and age of onset o40 years were defined as cases (n ¼ 2,582), and individuals with HN grade I and age X30 or HN grade II and age X50 were considered as controls (n ¼ 2,389). Individuals related to any individual included in our previous AGA meta-analysis (Li et al., 2012) were also excluded. A summary of the case-control samples used in this study is provided in Supplementary Table S1 online. All studies were approved by the institutional ethics review committees of the respective organizations. The studies were conducted in accordance with the Declaration of Helsinki Principles, and all participants provided written informed consent.
Genotyping
Genotyping for the ''Replication I'' sample was carried out on Sequenom's Mass Array System (Sequenom, San Diego, CA) using the iPlex Gold assay in a multiplex reaction. On the basis of the association signals obtained in the meta-analysis (Li et al., 2012) , 12 loci were selected, for which at least one SNP had attained an association signal of 5 Â 10
. For each locus, the two SNPs with the best association signals were selected for replication. SNP call rates of 90% were required for the analysis, and samples with call rates of o90% were excluded. Genotyping was successful for 21 of the 24 SNPs. All samples had genotyping call rates of 490%. Primer sequences and standard assay conditions are available upon request. Genotyping for the ''Replication II'' sample was performed using Illumina (San Diego, CA) genome-wide SNP arrays as previously described (Li et al., 2012) . A total of 315 individuals were genotyped using a custom version of the Illumina HumanHap550 array, and 4,656 were genotyped using a custom version of the Illumina OmniExpress. All individuals were phased using Beagle 3.3.1 (Browning and Browning, 2007) and imputed against 1,000 Genomes haplotypes (August 2010 release) using Minimac (2011-10-27) (Howie et al., 2012) . For the SNPs included in Table 1 , all had imputation r 2 40.8. Minor allele frequencies for the 24 SNPs in the replication samples are given in Supplementary  Table S2 online.
Statistical analysis
The Armitage trend test (Armitage, 1955) was used for the singlemarker analysis within the ''Replication I'' sample as implemented in the INTERSNP software package (Herold et al., 2009) . Only those SNPs that passed the following quality criteria were included in the analysis: minor allele frequency 41%, and deviation from HardyWeinberg equilibrium P-values (P HWE ) in cases 40.001 and in controls 40.05. Single-marker analysis for the ''Replication II'' sample was performed using logistic regression with allele dosages from imputation and including five principal components as covariates to control for differences in ancestry. One SNP, rs7349332, was directly genotyped but not present in the 1,000 Genomes imputation reference panel; for this SNP, we performed logistic regression using the observed genotypes. All tested SNPs had P HWE 40.01 across the tested individuals, rounding imputed allele dosages to the nearest genotype. A fixed-effects model (de Bakker et al., 2008) and a random-effects model (Higgins et al., 2003) were used to perform a meta-analysis of the data of all three studies (meta-analysis, ''Replication I,'' and ''Replication II''). To obtain OR estimates for the combined analysis, the allelic OR of the single studies were weighted according to their standard errors, and significance was assessed using the standard normal distribution (de Bakker et al., 2008) . The total variance Q was computed according to Cochrane (1954) , and the between-study variance I 2 was calculated as suggested by Higgins et al. (2003) . I 2 was used to determine whether a fixed-effects model or a random-effects model was appropriate. In case I 2 was significant after adjustment for the number of SNPs tested (n ¼ 24), a random-effects model was used instead of the fixed-effects model. However, we did not find evidence for heterogeneity across studies for the significant loci. We used the established significance threshold for GWAS of 5 Â 10 À 8 (Frazer et al., 2007) . Interaction analysis was carried out within an extended case-control sample of 4,737 AGA patients and 4,159 controls from the 23andMe genomic service. A model with a ''g1*g2'' term was fitted and then tested for significance of the g1:g2 interaction by analysis of variance.
Expression analysis
DNA from the whole blood and RNA from the occipital hair follicles of 98 population-based German controls (age 20-40 years) were collected. Total RNA was extracted from human hair follicles (RNeasy Micro Kit, Qiagen, Hilden, Germany). The quality and quantity of the RNA were analyzed on a NanoDrop ND-1000 spectrophotometer (Peqlab Biotechnologie, Erlangen, Germany). RNA samples were additionally checked for degradation via gel electrophoresis in a BioAnalyzer 2100 (Agilent Technologies, Waldbronn, Germany) using RNA 6000 nano lab chips, according to the manufacturer's instructions. The Illumina TotalPrep-96 RNA Amplification Kit (Illumina) was used for the amplification and biotinylation of the RNA. Subsequent array-based gene expression analysis of individual tissue samples was performed on Illumina's human HT12v4 Expression BeadChips using standard protocols (Illumina). The obtained fluorescence expression data were background subtracted and quantile normalized using the GenomeStudio software (Illumina). In the analysis of gene expression within human hair follicle, the AVG signal and the detection P-value were taken into account. Genes were assumed to be reliably expressed if the detection P-value was o0.01. If a gene or different transcripts of a gene were detected by more than one Illumina probe, the probe with the best expression values based on all samples tested was analyzed. Nonpresent fluorescence intensity after background subtraction or expression with detection P-value 40.01 was marked as ''-'' and defined as not expressed (Table 2) . To calculate genotype-specific expression, only those samples that showed detection P-values of o0.01 were taken into account. DNA extraction and genotyping was performed as described above. Genotype-specific expression levels were calculated from the normalized AVG signals for the respective gene-specific probe relative to the expression levels of individuals with the AGA nonrisk genotype, which was set to 100%. The R software (version 2.10.1; http:// www.R-project.org) was used for the statistical analysis, and P-values were calculated using a one-sided t-test.
Association with hair curl
To analyze for a potential etiological overlap between AGA and hair curl, we investigated all known AGA susceptibility loci for association with hair curl and vice versa. Hair curl was assessed and association tests were performed as previously described by Eriksson et al. (2010) using data from 29,353 unrelated individuals of European ancestry. We tested lead SNPs from a total of 12 AGA loci-the 8 loci identified in our previous meta-analysis (Li et al., 2012) and the 4 additional loci identified in this study-for association with hair curl.
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